2 completed. 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow AJM300: new trials by email Literature Review of AJM300 trials Research Report on AJM300
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Carotegrast Methyl in Ulcerative Colitis Carotegrast methyl - Ulcerative Colitis | Phase 4 | Completed | Takayuki Yamamoto | 50 | 2022-06-01 | 2025-04-02 |
| A Study to Evaluate the Safety and Efficacy of AJM300 in Participants With Active Ulcerative Colitis AJM300, Placebo - Colitis, Ulcerative | Phase 3 | Completed | EA Pharma Co., Ltd. | 198 | 2018-06-06 | 2023-07-21 |
Colitis, Ulcerative (2) · Colitis (1)
EA Pharma Co., Ltd. (1) · Takayuki Yamamoto (1)
Japan (2)
Takayuki Yamamoto, MD, PhD (1)